Ocean Park Asset Management LLC purchased a new position in shares of Centene Corporation (NYSE:CNC – Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 10,358 shares of the company’s stock, valued at approximately $339,000.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. DV Equities LLC bought a new position in shares of Centene during the 4th quarter worth approximately $26,000. IFC & Insurance Marketing Inc. bought a new stake in Centene in the 4th quarter valued at $28,000. SBI Securities Co. Ltd. lifted its holdings in Centene by 118.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock valued at $31,000 after purchasing an additional 406 shares during the last quarter. Bayban bought a new position in Centene during the fourth quarter worth $33,000. Finally, MV Capital Management Inc. acquired a new position in shares of Centene in the fourth quarter valued at $34,000. Institutional investors own 93.63% of the company’s stock.
Centene Trading Up 4.3%
CNC stock opened at $63.67 on Tuesday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.12 and a current ratio of 1.12. The company’s 50-day simple moving average is $54.52 and its 200 day simple moving average is $45.32. Centene Corporation has a 52 week low of $25.08 and a 52 week high of $66.55. The company has a market capitalization of $31.44 billion, a PE ratio of -4.85, a price-to-earnings-growth ratio of 0.48 and a beta of 1.09.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the stock. Mizuho set a $63.00 price objective on shares of Centene and gave the company a “neutral” rating in a research report on Monday, June 8th. Cantor Fitzgerald reiterated an “overweight” rating on shares of Centene in a research note on Thursday, June 11th. Bank of America increased their price target on shares of Centene from $72.00 to $74.00 and gave the company a “buy” rating in a report on Thursday, June 4th. Raymond James Financial set a $60.00 price objective on shares of Centene in a research report on Wednesday, April 29th. Finally, Deutsche Bank Aktiengesellschaft upgraded Centene from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $53.00 to $80.00 in a report on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, nine have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Centene has a consensus rating of “Hold” and a consensus target price of $60.24.
Check Out Our Latest Report on CNC
About Centene
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Featured Articles
- Five stocks we like better than Centene
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
